Hereditary Hemochromatosis is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Hereditary Hemochromatosis | |
|---|---|
| Gene | HFE (primary), HJV, HAMP, TFR2, SLC40A1 |
| Inheritance | Autosomal Recessive |
| Chromosome | 6p21.3 (HFE) |
| OMIM | 235200 (HFE-related) |
| Prevalence | 1 in 200-400 (C282Y homozygotes) |
Hereditary hemochromatosis (HH) is a group of autosomal recessive genetic disorders characterized by excessive iron accumulation in tissues throughout the body. The most common form is HFE-related hemochromatosis, caused by mutations in the HFE gene on chromosome 6p21.3. This condition leads to progressive iron overload in the liver, heart, pancreas, joints, and central nervous system, potentially causing severe organ damage if left untreated.
The HFE gene encodes the hereditary hemochromatosis protein, which regulates hepcidin expression—the key hormone controlling iron absorption in the intestine.[1] The two most common pathogenic variants are:
In hereditary hemochromatosis, the normal feedback mechanism linking body iron stores to intestinal iron absorption is disrupted. Normally, increased hepatic iron stores stimulate hepcidin production, which reduces intestinal iron absorption. In HH, this regulatory loop fails, leading to uncontrolled iron absorption from the diet.
The excess iron accumulates primarily in:
Iron deposition in the basal ganglia can lead to Parkinsonian features:
These symptoms may be misdiagnosed as idiopathic Parkinson's Disease, but typically lack the classic Lewy body pathology.
Iron accumulation in brain parenchyma is associated with:
Some studies suggest that iron overload may accelerate Alzheimer's Disease pathogenesis through:
Iron accumulation in the substantia nigra is a hallmark of Parkinson's Disease. Patients with hereditary hemochromatosis may have an increased risk of parkinsonian symptoms, and MRI findings in HH can resemble those seen in PD.
Elevated iron levels have been reported in ALS patients, and dysregulated iron metabolism may contribute to motor neuron degeneration. The relationship between HH and ALS remains an active area of research.
The study of Hereditary Hemochromatosis has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
This section highlights recent publications relevant to this disease.
[Reference missing - citation needed] ↩︎